Searched for
ZEMBRACESYMTOUCH
Dr Reddy's Lab shares gain over 3% on USFDA nod for productThe stock gained 3.21 per cent to settle at Rs 3,103.60 on BSE. Intra-day, it rose 3.58 per cent to Rs 3,115.29 Jan, 2016, 07.01 PM IST- Dr Reddy's gets USFDA nod for migraine injectionThe company has received an approval from the US Food and Drug Administration (USFDA) for ZembraceSymTouch injection, DRL said in a stateme...29 Jan, 2016, 05.02 PM IST
Load More